22
Sep2016

Imagine this scenario: you are a researcher conducting a clinical trial on a promising treatment for a rare but serious heart condition. Unfortunately, you are struggling to locate and enroll enough eligible participants and your study is at risk of not completing. Then you discover a Facebook support group for precisely the condition you are studying. The group is open: you do not need to be invited or to suffer from the condition to become a member—anyone can join. Here are the eligible participants you have been looking for! Read more

16
Sep2016

This week’s Research Ethics Roundup examines the best ways to stop research fraud, the National Institutes of Health’s workshop reviewing the ethics of nonhuman primate research, a large-scale data collection effort in New York, and an interview with the CEO of a biospecimen collection company.

Stop Ignoring Misconduct: In a Nature comment piece, Donald S. Kornfeld and Sandra L. Titus argue that irreproducibility of research results is the result of flawed research practices and fraud, and go on to note that “current initiatives to improve science dismiss the second factor.” To resolve the problem, they recommend several different approaches: new [...] Read more

6
Sep2016

In Case You Missed It (ICYMI): From time-to-time, PRIM&R will feature particularly well-received posts from the recent past. These posts remain timely as topics of discussion in the fields of research ethics, human subjects protections, or animal care and use. Highlighting them now enables readers who may have missed them a chance to read and comment. In this ICYMI, Michael Zimmer delves into one of the most important - and ethically fraught - new fields of research: Big Data. Read more

2
Sep2016

This week’s Research Ethics Roundup highlights the research implications of the Drug Enforcement Administration (DEA) decision to keep marijuana a Schedule 1 drug, public concern about hackers and stored genetic information, one bioethics professor’s take on the National Institutes of Health’s proposed policy for funding chimera research, and the European Medicines Agency’s response to a French clinical trial that left one man dead. Read more

28
Aug2016

In Case You Missed It (ICYMI): From time-to-time, PRIM&R will feature particularly well-received posts from the recent past. These posts remain timely as topics of discussion in the fields of research ethics, human subjects protections, or animal care and use. Highlighting them now enables readers who may have missed them a chance to read and comment. In this ICYMI, AER12 poster presenter Brandon Brown follows up on his initial findings regarding the incentives used to encourage participation in human subjects research. Read more

Page 1 of 16012345...102030...Last »